Usher Syndrome Type 1B
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Trial of AAVB-081 for Usher Syndrome Type 1B-Associated Retinitis Pigmentosa
AAVantgarde; LUCE-1; AAVB-081; Usher Syndrome Type 1B; USH1B; retinitis pigmentosa; gene therapy; clinical trial